Interested in Joining a Registry?
Request More Information.
Already an NCDR Participant?
NCDR Registry Login
New Renal Denervation Module™: Offering Procedural Treatment Insights on Patients with Hypertension
The Renal Denervation Module is currently in development, with more details coming soon. Be the first to receive updates, timelines and participation information. Sign up here.
Renal denervation (RDN) is emerging as an important therapy option for patients with uncontrolled or treatment‑resistant hypertension. As facilities, clinicians, and researchers prepare for broader adoption, the need for consistent, high‑quality real‑world data has never been greater.
The NCDR Renal Denervation Module will provide a national platform to collect and report on:
- Procedure utilization
- Safety and efficacy outcomes
- Durability and long‑term treatment impact
- Benchmarking and quality improvement insights
The module is designed to support clinical decision‑making, regulatory evidence needs, and the future of hypertension care.
Who Will Benefit
- Clinicians and Facilities Participating: Streamlined workflows, benchmarking tools and clear insights into emerging best practices.
- Hospital Administrators: Actionable data to support program oversight, quality initiatives and strategic planning.
- Researchers & Industry Partners: Access to real‑world evidence supporting safety, performance and post‑approval requirements.
- Patients: Improved access to safe, effective and well‑monitored hypertension treatment options.
